A novel mathematical approach to define the genes/SNPs conferring risk or protection in sporadic amyotrophic lateral sclerosis based on auto contractive map neural networks and graph theory

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Buscema, Massimo ^a   Penco, Silvana ^b   Grossi, Enzo ^c  

^a Semeion centro ricerche di scienze della communicazione   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Bracco SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866148793     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/478560     Document Type: Article

References (32)

1. Buscema M., A novel adapting mapping method for emergent properties discovery in data bases:experience in medical field. Proceedings of the IEEE International Conference on Systems, Man and Cybernetics (SMC '07) October 2007 Montreal, Canada
2. Tandan R., Bradley W. G., Amyotrophic lateral sclerosis: part I. Clinical features, pathology, and ethical issues in management. Annals of Neurology 1985 18 3 271 280 2-s2.0-0021809173 (Pubitemid 15023099)
3. Miller R. G., Mitchell J. D., Lyon M., Moore D. H., Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2007 1 CD001447 2-s2.0-34247887576
4. Beleza-Meireles A., Al-Chalabi A., Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotrophic Lateral Sclerosis 2009 10 1 1 14 2-s2.0-61549122708 10.1080/17482960802585469
5. Perry J. J. P., Shin D. S., Tainer J. A., Amyotrophic lateral sclerosis. Advances in Experimental Medicine and Biology 2010 685 9 20 2-s2.0-77955889112 10.1007/978-1-4419-6448-92
6. Penco S., Buscema M., Patrosso M., Marocchi A., Grossi E., New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. BMC Bioinformatics 2008 9 254 2-s2.0-46949107361 10.1186/1471-2105-9-254 (Pubitemid 351959567)
7. Buscema M., Squashing theory and contractive map network. Semeion Technical Paper 2007 32
8. Buscema M., Helgason C., Grossi E., Auto contractive maps, H function and maximally regular graph: theory and applications. Proceedings of the IEEE Special Session on Artificial Adaptive Systems in Medicine: applications in the real world (NAFIPS '08) May 2008 New York, NY, USA
9. Buscema M., Grossi E., Artificial Adaptive Systems in Medicine 2009 Oak Park, Ill, USA eBooks-Bentham Science Publishers
10. Kruskal B., On the shortest spanning subtree of a graph and the traveling salesman problem. Proceedings of the American Mathematical Society 1956 7 1 48 50
11. Karger D. R., Klein P. N., Tarjan R. E., Randomized linear-time algorithm to find minimum spanning trees. Journal of the ACM 1995 42 2 321 328 2-s2.0-0029276335 10.1145/201019.201022
12. Barabási A.-L., Network medicine-from obesity to the 'Diseasome' New England Journal of Medicine 2007 357 4 404 407 2-s2.0-34547146985 10.1056/NEJMe078114 (Pubitemid 47124144)
13. Massini G.,. Tree Visualizer, Semeion Software #40, ver. 8.0, 20062011, Rome
14. Vowinkel T., Mori M., Krieglstein C. F., Russell J., Saijo F., Bharwani S., Turnage R. H., Davidson W. S., Tso P., Granger D. N., Kalogeris T. J., Apolipoprotein A-IV inhibits experimental colitis. Journal of Clinical Investigation 2004 114 2 260 269 2-s2.0-4043165724 10.1172/JCI200421233 (Pubitemid 39071631)
15. Lu Y., Dollé M. E. T., Imholz S., van't Slot R., Verschuren W. M. M., Wijmenga C., Feskens E. J. M., Boer J. M. A., Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. Journal of Lipid Research 2008 49 12 2582 2589 2-s2.0-59649099369 10.1194/jlr.M800232-JLR200
16. Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J. L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J. J., Lacomblez L., Loeffler J. P., Meininger V., Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008 70 13 1004 1009 2-s2.0-41349122697 10.1212/01.wnl.0000285080.70324.27 (Pubitemid 351451324)
17. Chiò A., Calvo A., Ilardi A., Cavallo E., Moglia C., Mutani R., Palmo A., Galletti R., Marinou K., Papetti L., Mora G., Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 2009 73 20 1681 1685 2-s2.0-73449097789 10.1212/WNL.0b013e3181c1df1e
18. Siciliano G., D'Avino C., Del Corona A., Barsacchi R., Kusmic C., Rocchi A., Pastorini E., Murri L., Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002 3 2 57 62 2-s2.0-0036388399 10.1080/ 146608202760196011
19. Baillet A., Chanteperdrix V., Trocmé C., Casez P., Garrel C., Besson G., The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochemical Research 2010 35 10 1530 1537 2-s2.0-77957562993 10.1007/s11064-010-0212-5
20. Fan Y. M., Raitakari O. T., Kähönen M., Hutri-kähönen N., Juonala M., Marniemi J., Viikari J., Lehtimäki T., Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clinical Genetics 2009 76 1 46 53 2-s2.0-67650901254 10.1111/j.1399-0004.2009. 01180.x
21. McCaskie P. A., Cadby G., Hung J., McQuillan B. M., Chapman C. M. L., Carter K. W., Thompson P. L., Palmer L. J., Beilby J. P., The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease. Clinical Genetics 2006 70 2 114 121 2-s2.0-33745845544 10.1111/j.1399-0004.2006.00659.x (Pubitemid 44028096)
22. 3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress. Behavioural Brain Research 2010 206 2 310 312 10.1016/j.bbr.2009.09.003
23. 3-adrenergic receptor gene is associated with obesity and byperinsulinemia in Japanese subjects. Biochemical and Biophysical Research Communications 1995 215 2 555 560 10.1006/bbrc.1995.2500
24. Santiago C., Ruiz J. R., Buxens A., Artieda M., Arteta D., González-Freire M., Rodríguez-Romo G., Altmäe S., Lao J. I., Gómez-Gallego F., Lucia A., Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. British Journal of Sports Medicine 2011 45 2 147 149 2-s2.0-79551502591 10.1136/bjsm.2009.061366
25. Piazza O., Sirén A. L., Ehrenreich H., Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Current Medical Research and Opinion 2004 20 4 505 508 2-s2.0-1942502762 10.1185/030079904125003296 (Pubitemid 38525158)
26. Beghi E., Logroscino G., Chiò A., Hardiman O., Millul A., Mitchell D., Swingler R., Traynor B. J., Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotrophic Lateral Sclerosis 2010 11 3 289 292 2-s2.0-77952167588 10.3109/17482960903384283
27. Renaud S., Leppert D., Matrix metalloproteinases in neuromuscular disease. Muscle and Nerve 2007 36 1 1 13 2-s2.0-34347351239 10.1002/mus.20772 (Pubitemid 47016155)
28. Choi I., In Yang Y., Song H.D., Lee J.S., Kang T., Sung J.-J., Yi J., Lipid molecules induce the cytotoxic aggregation of Cu/Zn superoxide dismutase with structurally disordered regions. Biochimica et Biophysica Acta 2011 1812 1 41 48 10.1016/j.bbadis.2010.09.003
29. Chiò A., Calvo A., Ilardi A., Cavallo E., Moglia C., Mutani R., Palmo A., Galletti R., Marinou K., Papetti L., Mora G., Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 2009 73 20 1681 1685 2-s2.0-73449097789 10.1212/WNL.0b013e3181c1df1e
30. Panov A., Kubalik N., Brooks B. R., Shaw C. A., In vitro effects of cholesterol β -d-glucoside, cholesterol and cycad phytosterol glucosides on respiration and reactive oxygen species generation in brain mitochondria. Journal of Membrane Biology 2010 237 2-3 71 77 2-s2.0-78649960521 10.1007/s00232-010-9307-9
31. Adibhatla R. M., Hatcher J. F., Altered lipid metabolism in brain injury and disorders. Sub-Cellular Biochemistry 2008 49 241 268 2-s2.0-58149308844
32. Valenza M., Cattaneo E., Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list? Progress in Neurobiology 2006 80 4 165 176 2-s2.0-33751399202 10.1016/j.pneurobio.2006.09.005 (Pubitemid 44821504)